Sobeida Dilone

2 days ago | citybiz.co | Sobeida Dilone

EyeCare4Kids™, a nonprofit organization that provides vision care for underserved children and families across the Southwest United States and Africa, has named Maggie Cline, MPH, as its new Chief Executive Officer. The announcement marks a leadership transition as founder Joseph Carbone steps into a new role leading the group’s expanding efforts across the African continent.

2 days ago | citybiz.co | Sobeida Dilone

The Boys & Girls Clubs of Palm Beach County is thrilled to launch its Annual 2025 Back-to-School Drive, proudly presented by Office Depot® OfficeMax®. Running from Monday, June 2 through Friday, August 1, this impactful initiative will help ensure that more than 9,000 local Club members return to the classroom this fall with the tools they need to thrive.

2 days ago | citybiz.co | Sobeida Dilone

At a time when investors, consumers, and talent are all demanding more from the companies they support, Delivering Good’s 2025 Women of Impact Summit made a bold and timely statement: the future of leadership is purpose-driven, collaborative, and deeply personal. The Lead Sponsors were The Knitwell Group and Macy’s, and the Inspiration Sponsors were Centric Brands, G-III Apparel Group, and The O’Alliance.

2 days ago | citybiz.co | Sobeida Dilone

MCB Real Estate, an institutional commercial real estate investment management firm with nationwide holdings, has secured leases for two new restaurant tenants at Yard 56, the developer’s contemporary mixed-use property comprising 100,000 square feet of retail, multifamily, and medical office space in East Baltimore. The national award-winning burger chain Five Guys, and The Breakfast Club, an upscale, all-day breakfast and brunch restaurant, will bring Yard 56 to 97% occupied.

2 days ago | citybiz.co | Sobeida Dilone

NeOnc Technologies Holdings, a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system cancers and disorders, today announced the appointment of Josh Neman, PhD as its new Chief Clinical Officer (CCO). Dr. Neman brings with him a distinguished career at the intersection of cancer neuroscience, translational research, and academic medicine. Dr. Neman joins NeOnc Technologies Holdings Inc.